IP Library Granted Patent US 11,446,654
Granted Patent B2
US 11,446,654 · App. 15/893,375 · Granted Sep 20, 2022

Substrate with channels for controlled fluid flow

Inventors: Samantha Chang (San Marcos, CA); Jason McClure (San Diego, CA); Robert Reed (Carlsbad, CA); Irene Sinn Blandy (San Diego, CA); Robert Weiller (Encinitas, CA); Christian Bobritchi (San Diego, CA)
Assignee: Quidel Corporation
B01L3/5023B01L3/5027G01N33/54386G01N33/558B01L2300/0858B01L2300/0861B01L2400/082G01N33/569
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,446,654
App. No.
15/893,375
Granted
Sep 20, 2022
Kind
B2
Abstract

A substrate structured to define thereon a fluid flow channel and/or a fluid control feature is described. The substrate may additionally comprise a capture zone and/or a test zone, for use as a test strip for determining presence or absence of an analyte of interest, such as an infectious agent or a biomarker. Reagents are deposited in the capture zone and/or test zone as an array of drops.

Claims (17)

1. An immunoassay device, comprising:

a substrate comprised of a plurality of parallel fluid flow channels, wherein each parallel fluid flow channel is separated from an adjacent parallel fluid flow channel by a substrate-devoid gap, and wherein the substrate-devoid gaps form side channels that are impermeable to fluid flow;

a fluid control feature positioned in each fluid flow channel to form a plurality of fluid flow control features ablated or etched on the substrate;

a single sample receiving zone positioned on the substrate to distribute a portion of a sample deposited thereon to each fluid flow channel in the plurality of parallel fluid flow channels;

a label zone in each of the fluid flow channels; and

a capture zone downstream of the label zone in each of the fluid flow channels,

wherein the label zone, the capture zone, or both the label zone and the capture zone comprise a reagent comprising a binding member.

2. The device of claim 1 , wherein the plurality of fluid flow channels comprises between 3-50 fluid flow channels.

3. The device of claim 1 , wherein the sample receiving zone dispenses sample to each channel in essentially equal amounts and at essentially equal rates.

4. The device of claim 1 , wherein the substrate comprises a laminate of nitrocellulose and a hydrophobic support layer.

5. The device of claim 1 , wherein the binding member in the capture zone in each of the plurality of parallel fluid flow channels is an immobilized binding member that binds a conjugate, wherein the conjugate is comprised of a detectable species and an antibody.

6. The device claim 5 , wherein the detectable species is an antibody with a label.

7. The device of claim 6 , wherein the label is a fluorescent or chemiluminescent marker.

8. The device of claim 5 , wherein the detectable species is a europium bead.

9. The device of claim 1 , wherein each fluid control feature in the plurality of fluid control features is in a flow rate control zone disposed downstream of the sample receiving zone.

10. The device of claim 9 , wherein the flow rate control zone is disposed between the sample receiving zone and the label zone.

11. The device claim 1 , wherein the substrate comprises nitrocellulose.

Assignments (7)
SECURITY AGREEMENT Recorded Aug 22, 2025
From: CRIMSON INTERNATIONAL ASSETS LLC; MICRO TYPING SYSTEMS, INC.; ORTHO-CLINICAL DIAGNOSTICS, INC.; QUIDEL CARDIOVASCULAR INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 072526/0643 →
RELEASE (REEL 060220 / FRAME 0711) Recorded Aug 22, 2025
From: BANK OF AMERICA, N.A.
To: QUIDEL CORPORATION; BIOHELIX CORPORATION; DIAGNOSTIC HYBRIDS, INC.; QUIDEL CARDIOVASCULAR INC.; ORTHO-CLINICAL DIAGNOSTICS, INC.; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC; MICRO TYPING SYSTEMS, INC.
Reel/Frame 072577/0536 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 15, 2024
From: QUIDEL CORPORATION
To: ORTHO-CLINICAL DIAGNOSTICS, INC.
Reel/Frame 068657/0827 →
RELEASE OF SECURITY INTEREST Recorded May 31, 2022
From: BANK OF AMERICA, N.A.
To: QUIDEL CORPORATION
Reel/Frame 060053/0068 →
SECURITY AGREEMENT Recorded May 31, 2022
From: QUIDEL CORPORATION; BIOHELIX CORPORATION; DIAGNOSTIC HYBRIDS, INC.; QUIDEL CARDIOVASCULAR INC.; ORTHO-CLINICAL DIAGNOSTICS, INC.; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC; MICRO TYPING SYSTEMS, INC.
To: BANK OF AMERICA, N.A.
Reel/Frame 060220/0711 →
SECURITY INTEREST Recorded Aug 31, 2018
From: QUIDEL CORPORATION
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 046767/0745 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 9, 2018
From: CHANG, SAMANTHA; MCCLURE, JASON; REED, ROBERT; BLANDY, IRENE SINN; WEILLER, ROBERT; BOBRITCHI, CHRISTIAN
To: QUIDEL CORPORATION
Reel/Frame 044886/0495 →
Continuity (4)
Provisional Application 62598947 · Dec 14, 2017
Provisional Application 62472182 · Mar 16, 2017
Provisional Application 62457660 · Feb 10, 2017
Related Publication 20180229232A1 · Aug 16, 2018